Clinical Trial Update: Efficacy and Safety Study of 610 in Patients With Severe Asthma [Phase 3]

View source ↗

Summary

This update notes that a Phase 3 trial evaluating the efficacy and safety of 610 for severe asthma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• 610

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Asthma | Phase 3 | Status: RECRUITING